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More May Not Always Be Better*
Arthur E. Weyman, MD
Boston, Massachusettsi
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wThe study by Gaibazzi et al. (1) in this issue of
iJACC sought to determine whether there is suffi-
cient additional prognostic information provided by
adding Doppler coronary flow reserve in the left
anterior descending coronary artery (CFR-LAD)
and myocardial perfusion imaging (MP) to stan-
dard wall motion analysis (WM) and clinical pa-
rameters (PARA) during vasodilator stress echocar-
diography to justify the additional complexity of the
combined tests. The investigators studied 752 pa-
tients undergoing contrast high-dose dipyridamole
stress echocardiography (SE) with suspected or
known coronary artery disease (one-third). The
cohort was followed for a median of 16.5
See page 1
months post-testing and the ability of individual
and combined measures to predict risk of cardiac
events (death, nonfatal myocardial infarction, or
acute coronary syndromes) was studied using mul-
tivariate models and risk reclassification. The study
found that reversible WM abnormalities were pres-
ent in 18% of patients compared with 27% with
inducible myocardial perfusion defects (MPD) and
38% with reduced CFR-LAD. Presence of any SE
abnormality had a higher event rate than did
normal SE (10.8% vs. 2.1%, p  0.001). Multivar-
iate analysis showed that when combined with
clinical risk parameters, the sequential addition of
WM, WM  CFR 2, MPD alone, and WM 
CFR 2MPD progressively improved risk strat-
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.
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Nagueh, MD, served as Guest Editor for this paper.fication. The study is of interest because of the
arge number of patients analyzed and the investi-
ators’ prior experience with these techniques, par-
icularly CFR-LAD and dipyridamole SE. How-
ver, as in most studies, the nature of the
xperimental model and complexity of the protocol
hosen affect a number of results reported and thus
re worthy of further examination.
The first relates to the type of echocardiographic
tress testing performed. Most clinical laboratories
refer to use exercise stress where possible for a
umber of reasons including: 1) physiological cor-
elation of ischemia with exercise and its signifi-
ance at varying workloads; 2) the established value
f exercise as a prognostic determinant; 3) the
reater potency of exercise versus pharmacological
tressors; 4) the complementary information de-
ived from electrocardiogram changes consistent
ith ischemia and the detection of arrhythmias
ccurring during exercise; and 5) the ability to relate
he presence and nature of symptoms or lack thereof
uring exercise to the patient’s pre-test complaints.
he investigators acknowledge that exercise might
ave been considered the best protocol in their
atients who could exercise, but they selected phar-
acological stress presumably due to the extreme
ifficulty in recording coronary flow by Doppler in
he exercising patient. In patients who are unable to
xercise, pharmacological stress testing is appropri-
te with dobutamine employed most commonly in
aboratories in the United States, whereas dipyri-
amole (as in this study) or adenosine is often used
n Europe. Because these agents have different
echanisms of action, their appropriateness for
ifferent types of testing varies. Dobutamine, by
ncreasing heart rate, blood pressure, and contrac-
ility, increases demand in the face of limited supply
ith resulting ischemia, whereas dipyridamole and
denosine create relative differences in flow between
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14regions supplied by normal and stenotic vessels
(MP) or between resting and vasodilator flow in the
region of a coronary artery distal to a stenosis
(CFR). Production of ischemia in the latter case
then depends on the presence of either vertical or
horizontal steal phenomena that are more difficult
to predict (2). In theory, the former method would
appear to be preferable for WM analysis, and the
latter would be better suited to demonstrate flow
abnormalities; indeed, experimental and clinical
studies support this concept. Experimental studies
comparing dobutamine and dipyridamole have
shown that dipyridamole produces segmental dys-
function less often and, when present, the degree of
dysfunction is less (3,4). In a clinical study of 97
patients undergoing coronary angiography without
prior infarcts, Marwick et al. (5) reported a sensi-
tivity of 59% for adenosine SE compared with 86%
for dobutamine SE for the detection of WM
abnormalities in the same patients. The percentage
of nondiagnostic studies was also higher for the
adenosine stress studies (5). In addition to the
stressor, the nature of image acquisition may also
adversely affect the WM analysis. It is standard
practice that the minimum views required for an
adequate SE include parasternal long- and short-
axis views (papillary muscle level) with additional
short-axis views being desirable in addition to apical
recordings (6). In this study, only apical views were
recorded as these are more appropriate for the
perfusion and coronary flow studies, but unfortu-
nately, they select against the WM analysis. Al-
though the addition of contrast should have im-
proved endocardial definition, this can create its
own problems when only apical views are used.
Finally, as the investigators point out, censoring of
patients undergoing early revascularization may
have also led to a more pronounced underestima-
tion of WM abnormalities, because their presence
and extent are used as an indication for revascular-
ization. Thus, although WM performed least well
in this study, the study was designed to facilitate
coronary and perfusion analysis at the expense of
WM; hence, the value of this parameter in a more
appropriate setting is likely understated.
Second, in this study, CFR-LAD detected ab-
normal flow more often than MP. This is surprising
because CFR looks only at flow in a distal segment
of the LAD, which is not involved in all patients
with coronary artery disease (72% to 84%) (7,8),
whereas MP looks at the entire ventricle. Because
there is no gold standard, one can only speculate
that this may also relate to the production of dischemia as it is likely more difficult to distinguish
normal from increased flow (due to signal satura-
tion) than from reduced flow by visual assessment
of contrast. Alternatively, as the investigators note,
140 patients had abnormal WM or CFR with
normal MP, mostly because of reduced CFR-LAD
with normal WM that was presumed due to errors
in the CFR measurements or microvascular disease.
Because 83 of the 129 patients with WMA had
WMA and abnormal CFR-LAD, at least 94 pa-
tients (140 minus 46) must have had abnormal
CFR with normal WM and MP or 27% of the
positive studies. As the authors point out, the
majority of these abnormalities resulted from bor-
derline values, however, they are still classified as
abnormal, which affects the risk assessment. Fur-
ther, by employing 3 tests, one increases the prob-
ability of discrepant results, and the physician must
then decide whether to rely on the approach felt to
be most accurate or the majority.
Third, while univariate analysis demonstrated
that multiple clinical (hypercholesterolemia, diabe-
tes, known CAD, and aspirin therapy) and SE
(WM, CFR, and MP) parameters along with re-
duced resting LVEF were predictive of risk, on
multivariate analysis of SE parameters WM was no
longer independently predictive. Although both
CFR and MP remained independent predictors the
latter was clearly the stronger of the two (HR 2.25
vs. 5.97). The authors then look at the sequential
addition of WM, WM/CFR, MP alone, and WM/
CFRMP to clinical parameters in the prediction
model and show that there is incremental improve-
ment, however, in the end there is no significant
difference between the combinedmodel (PARAWM/
FRMP) and clinical parameters and MP alone.
hus, while the authors argue that in this model it
s important to add either CFR or MP to wall
otion analysis, which the data supports, it is not
lear that adding CFR and WM is better than
imply analyzing MP alone and avoiding the added
omplexity of the CFR study.
Finally, given the complexity of this protocol one
ight ask whether this approach is equivalent or
uperior to exercise or dobutamine stress echo for
outine clinical use. Although this question was not
ddressed in this study, the answer in all likelihood
elates to the difference between feasibility and
racticality. Although clearly not perfect, the feasi-
ility and practicality of exercise and dobutamine
tress echocardiography are well established and
tandard practice in most laboratories. In contrast,
espite numerous reports describing the diagnostic
m
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15accuracy and prognostic value of MP and CFR,
they have not been widely employed beyond dedi-
cated research laboratories. For CFR, the ability to
record a small vessel moving in space was hard in
the beginning and, despite the use of color flow and
contrast, is technically demanding now. For Dopp-
ler studies, this is further complicated by the need to
maintain the sample volume within the small,
moving vessel, the varying intensity of the contrast
following bolus injection that will affect the mea-
sured velocity, and the difficulty in aligning the
beam to optimally report flow velocity. Whereas the
advantage of this technique is that it provides a
quantitative measure, the need to average the 3
“best” flow profiles adds a subjective component and
as the investigators note, ratios can vary across the
threshold of 2 in the same patient. Feasibility has
also been a problem for MP. Although the inves-
tigators state that the test was deemed uninterpre-
table for at least 1 of the 3 tested parameters in only
4% of patients, the group does not appear to have
been consecutive; the number excluded for poor
echocardiographic window was unstated; and the
number of left ventricular segments excluded from
MP interpretation if they were not clearly visual-coronary stenosis. Circulation 1987;76:
943–51.
4
5
6
stress testing? Echoc
16:841–56.penetration, is unclear. Again, as the investigators
point out, perfusion imaging is limited by technical
complexity and subjectivity in its interpretation.
Furthermore, there has been a failure to agree on a
standardized technique or protocol for test perfor-
mance among different groups with resulting vari-
ations in contrast delivery (e.g., bolus vs. infusion),
contrast agents, instrument settings, and image
capture and display formats. Interobserver variabil-
ity has also been a problem. As noted, the interob-
server agreement in this study for MP was 80%
versus 95% for WM. Although the investigators
clearly acknowledge these limitations in the aggre-
gate, they represent the difference between tech-
niques that, at present, are feasible when performed
by experts and those that are practical for routine
clinical application. Whether this will change with
better standardization of methods, broader clinical
experience, and studies comparing both methods in
the same patients remains to be seen.
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